Novo Holdings A/S

Insider Reports History

Entity
Company
Location
Tuborg Havnevej 19, Hellerup, Denmark
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Novo Holdings A/S:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. 10%+ Owner COMMON STOCK 4.02M $222M $55.27 Feb 8, 2022 Direct
Edgewise Therapeutics, Inc. 10%+ Owner COMMON STOCK 6.07M $95.8M $15.78 Sep 14, 2022 Direct
Disc Medicine, Inc. 10%+ Owner Common Stock 1.09M $73.8M $67.65 Jun 28, 2023 Direct
Checkmate Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.16M $22.6M $10.45 Feb 25, 2022 Direct
Reneo Pharmaceuticals, Inc. 10%+ Owner Common Stock 3.33M $20.9M $6.28 Jun 23, 2023 Direct
Inogen Inc 10%+ Owner COMMON STOCK 2.08M $11.9M $5.72 Jun 2, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner COMMON STOCK 793K $7.93M $10.00 Jun 21, 2021 Direct
Cyteir Therapeutics, Inc. 10%+ Owner Common Stock 3.52M $5.95M $1.69 Jul 20, 2023 Direct
IO Biotech, Inc. 10%+ Owner COMMON STOCK 4.35M $5.71M $1.31 Jul 26, 2024 Direct
Metagenomi, Inc. 10%+ Owner COMMON STOCK 1.74M $5.01M $2.88 Feb 13, 2024 Direct
Bolt Biotherapeutics, Inc. 10%+ Owner COMMON STOCK 3.7M $3.52M $0.95 Jul 13, 2022 Direct
SPRUCE BIOSCIENCES, INC. 10%+ Owner COMMON STOCK 2.55M $1.92M $0.75 Mar 21, 2024 Direct
MINERVA SURGICAL INC 10%+ Owner COMMON STOCK 2.06M $421K $0.20 Oct 26, 2021 Direct
IO Biotech, Inc. 10%+ Owner Common Stock Warrant (Right to Buy) 2.47M Aug 9, 2023 Direct
Arcellx, Inc. 10%+ Owner SERIES A PREFERRED STOCK 0 Feb 8, 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES B-1 PREFERRED STOCK 0 Feb 8, 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES B-2 PREFERRED STOCK 0 Feb 8, 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES C PREFERRED STOCK 0 Feb 8, 2022 Direct
Metagenomi, Inc. 10%+ Owner SERIES B-1 PREFERRED STOCK 0 Feb 13, 2024 Direct
Metagenomi, Inc. 10%+ Owner SERIES B PREFERRED STOCK 0 Feb 13, 2024 Direct
MINERVA SURGICAL INC 10%+ Owner SERIES D REDEEMABLE CONVERTIBLE PREFERRED STOCK 0 Oct 26, 2021 Direct
MINERVA SURGICAL INC 10%+ Owner SUBORDINATED SECURED CONVERTIBLE PROMISSORY NOTES 0 Oct 26, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner SERIES B CONVERTIBLE PREFERRED STOCK 0 Jun 21, 2021 Direct

Insider Reports Filed by Novo Holdings A/S

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IOBT IO Biotech, Inc. Jul 25, 2024 2 -$99.1K 4 Jul 26, 2024 10%+ Owner
IOBT IO Biotech, Inc. May 10, 2024 1 -$802K 4 May 14, 2024 10%+ Owner
SPRB SPRUCE BIOSCIENCES, INC. Mar 21, 2024 1 -$351K 4 Mar 25, 2024 10%+ Owner
SPRB SPRUCE BIOSCIENCES, INC. Mar 18, 2024 3 -$1.36M 4 Mar 20, 2024 10%+ Owner
SPRB SPRUCE BIOSCIENCES, INC. Mar 14, 2024 1 -$1.7M 4 Mar 18, 2024 10%+ Owner
MGX Metagenomi, Inc. Feb 9, 2024 5 $13M 4 Feb 15, 2024 10%+ Owner
IOBT IO Biotech, Inc. Feb 9, 2024 1 -$988K 4 Feb 13, 2024 10%+ Owner
MGX Metagenomi Technologies, LLC Feb 8, 2024 0 $0 3 Feb 8, 2024 10%+ Owner
IOBT IO Biotech, Inc. Aug 9, 2023 2 $10M 4 Aug 11, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jul 19, 2023 2 -$280K 4 Jul 20, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jul 14, 2023 3 -$106K 4 Jul 18, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 30, 2023 1 -$529K 4 Jul 3, 2023 10%+ Owner
IRON Disc Medicine, Inc. Jun 28, 2023 1 -$57.6M 4 Jun 28, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 26, 2023 2 -$71.8K 4 Jun 28, 2023 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. Jun 23, 2023 1 -$710K 4 Jun 23, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 21, 2023 3 -$25.9K 4 Jun 23, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 15, 2023 3 -$34K 4 Jun 20, 2023 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 12, 2023 3 -$13.4K 4 Jun 14, 2023 10%+ Owner
SPRB SPRUCE BIOSCIENCES, INC. Feb 16, 2023 2 $7M 4 Feb 21, 2023 10%+ Owner
IRON Disc Medicine, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 10%+ Owner
EWTX Edgewise Therapeutics, Inc. Sep 14, 2022 1 $5M 4 Sep 16, 2022 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jul 20, 2022 1 -$2.7M 4 Jul 22, 2022 10%+ Owner
BOLT Bolt Biotherapeutics, Inc. Jul 13, 2022 1 -$1.6M 4 Jul 15, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. Feb 23, 2022 3 -$23.1K 4 Feb 25, 2022 10%+ Owner
ACLX Arcellx, Inc. Feb 8, 2022 6 $12.5M 4 Feb 9, 2022 10%+ Owner
ACLX Arcellx, Inc. Feb 3, 2022 0 $0 3 Feb 3, 2022 10%+ Owner
IOBT IO Biotech, Inc. Nov 9, 2021 4 $4.55M 4 Nov 10, 2021 10%+ Owner
IOBT IO Biotech, Inc. Nov 4, 2021 0 $0 3 Nov 4, 2021 10%+ Owner
UTRS MINERVA SURGICAL INC Oct 26, 2021 5 $1.41M 4 Oct 27, 2021 10%+ Owner
UTRS MINERVA SURGICAL INC Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 22, 2021 4 $5M 4 Jun 23, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 3 $6.65M 4 Jun 22, 2021 10%+ Owner
CYT Cyteir Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner
INGN Inogen Inc Jun 2, 2021 1 -$39M 4 Jun 3, 2021 10%+ Owner
SPRB SPRUCE BIOSCIENCES, INC. May 19, 2021 1 -$6.6M 4 May 21, 2021 10%+ Owner